AEON Biopharma
AEON
73 hedge funds and large institutions have $205M invested in AEON Biopharma in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
3% more funds holding
Funds holding: 71 → 73 (+2)
1% more capital invested
Capital invested by funds: $202M → $205M (+$2.65M)
0.05% more ownership
Funds ownership: 1.04% → 1.09% (+0.05%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$5.51M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$5.13M |
| 3 |
Parallax Volatility Advisers
San Francisco,
California
|
+$2.91M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$2.45M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$5.51M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4.89M |
| 3 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$1.22M |
| 4 |
JP Morgan Chase
New York
|
-$1.01M |
| 5 |
AR
Advisory Research
Chicago,
Illinois
|
-$991K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
JP Morgan Chase
New York
| – | -$1.01M | -1,432 | Closed |
|
|
EH
77
EMG Holdings
Old Greenwich,
Connecticut
| – | -$520K | -739 | Closed |
|
|
GH
78
GAM Holding
Zurich,
Switzerland
| – | -$328K | -465 | Closed |
|
|
ICMH
79
Integrity Capital Management (HK)
Central,
Hong Kong
| – | -$293K | -417 | Closed |
|
AEON Hedge Fund Activity: Q2 2022 in Review
73 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma (AEON) for Q2 2022, worth a combined $205M — up 1.3% from $202M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new AEON positions and 6 closed out — a net gain of 2 holders — while 12 added to existing stakes and 6 trimmed.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $5.51M. The largest seller was Linden Advisors, cutting an estimated $5.51M.
- 73 institutional investors held AEON Biopharma (AEON) as of Q2 2022, up from 71 in Q1 2022.
- Funds reported $205M of AEON Biopharma stock for Q2 2022, up 1.3% quarter-over-quarter.
- 8 funds opened new AEON Biopharma positions in Q2 2022 and 6 closed out, a net change of +2 holders.
- The largest AEON Biopharma buyer in Q2 2022 was Bank of Montreal, an estimated $5.51M added.
- The largest AEON Biopharma seller in Q2 2022 was Linden Advisors, an estimated $5.51M sold.
Based on aggregated 13F filings for Q2 2022.